AppLovin Announces First Quarter 2024 Financial Results
AppLovin Corporation (NASDAQ: APP) ("AppLovin"), a leading marketing platform, today announced financial results for the first quarter ended March 31, 2024 and posted a letter to its shareholders on its Investor Relations website located at https://investors.applovin.com.
Webcast and Conference Calls
AppLovin will host a webinar today at 2:00 PM PT / 5:00 PM ET, during which management will discuss the Company's first quarter 2024 results and provide commentary on the business' performance. A question-and-answer session will follow the prepared remarks.
AppLovin makes technologies that help businesses of every size connect to their ideal customers. The company provides end-to-end software and AI solutions for businesses to reach, monetize and grow their global audiences. For more information about AppLovin, visit: www.applovin.com.
FPT Software signed a Memorandum of Understanding (MOU) with JAL Information Technology (JIT), a subsidiary of JAL Infotec - an aviation technology solutions and services provider under Japan Airlines. This partnership will see both sides...
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...
Full Sail University's Annual Hall of Fame week kicked off with "Hall of Game." This esports event welcomed students and alumni to compete in popular titles including Call of Duty, Rocket League, and Super Smash Bros. Through Full Sail's partnership...
TIER IV, a pioneer in developing open-source software for autonomous driving (AD) systems, is set to launch a unique robotaxi service in November 2024. Initially targeting areas and times that conventional taxi operators struggle to serve, the...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
